# Vmax Detection of Acupuncture-doxofylline as a Whole Probe of CYP1A in Vivo

> **NCT05154942** · NA · UNKNOWN · sponsor: **Shanghai Yueyang Integrated Medicine Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Acupuncture
- Drug Interaction

## Interventions

- **DEVICE:** DOXO+electroacupuncture

## Key facts

- **NCT ID:** NCT05154942
- **Lead sponsor:** Shanghai Yueyang Integrated Medicine Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-15
- **Primary completion:** 2023-09-15
- **Final completion:** 2023-11-15
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2021-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05154942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05154942, "Vmax Detection of Acupuncture-doxofylline as a Whole Probe of CYP1A in Vivo". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05154942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*